TIDMEDEN

RNS Number : 2893K

Eden Research plc

01 September 2021

1 September 2021

Eden Research Plc

("Eden" or "Company")

Issuing of Annual Report & Notice of General Meeting

Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in global crop protection, animal health and consumer products industries, announces that its 2020 Annual Report and Notice of a General Meeting ("GM") have been issued to shareholders and are now available on the Company's website: www.edenresearch.com

Following the Company's 2021 Annual General Meeting ("AGM"), which was held on 30 June 2021, at which time it was not possible to lay before shareholders the Company's 2020 Annual Report, a General Meeting is being held at 12.00pm on Friday, 24 September 2021 at 67C Innovation Drive, Milton Park, Abingdon, Oxfordshire, OX14 4RQ where the sole resolution will be to lay before members the 2020 Annual Report.

In view of the minimal business to be transacted at the GM and as the Company's AGM was held recently, where a presentation and questions and answers session took place, Shareholders are discouraged from attending the GM.

There will be no presentation or questions and answers session at the GM.

Should Shareholders wish to ask any questions in relation to the Resolution, which they may otherwise have asked at the GM, had they been in attendance, they are encouraged to contact the Company prior to the GM by email at gm@edenresearch.com .

For further information contact:

 
 Eden Research plc                                    www.edenresearch.com 
 Sean Smith 
  Alex Abrey                                                 01285 359 555 
 
 Cenkos Securities plc (Nominated advisor 
  and broker) 
 Giles Balleny / Camilla Hume / Mark Connelly 
  (corporate finance) 
  Michael Johnson (sales)                                    020 7397 8900 
 
 Hawthorn Advisors (Financial PR) 
 Victoria Ainsworth                              eden@hawthornadvisors.com 
  Johanna Pemberton

Notes to Editors:

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden's products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides. Eden has two products currently on the market:

Mevalone (R) / Araw(R) is a foliar biofungicide which initially targets a key disease affecting grapes and other high-value fruit and vegetable crops. It is approved for sale in a number of key countries whilst Eden and its partners pursue regulatory clearance in new territories thereby growing Eden's addressable market globally.

Cedroz (TM) is a bionematicide that targets free living nematodes which are parasitic worms that affect a wide range of high-value fruit and vegetable crops globally. Cedroz is registered for sale on two continents and Eden's commercial collaborator, Eastman Chemical, is pursuing registration and commercialisation of this important new product in numerous countries globally.

Eden's Sustaine (R) encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally-derived, plastic-free, biodegradable micro-spheres derived from yeast. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.

Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN. It was awarded the London Stock Exchange Green Economy Mark in January 2021, which recognises London-listed companies that derive over 50% of their total annual revenue from products and services that contribute to the global green economy. Eden derives 100% of its total annual revenues from sustainable products and services.

For more information about Eden, please visit: www.edenresearch.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOGBLGDIXXXDGBB

(END) Dow Jones Newswires

September 01, 2021 02:00 ET (06:00 GMT)

Eden Research (LSE:EDEN)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024 Haga Click aquí para más Gráficas Eden Research.
Eden Research (LSE:EDEN)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024 Haga Click aquí para más Gráficas Eden Research.